Recent Updates
Recently added Catalysts
ATHE Negative Sentiment Score: 40/100

Notification of cessation of +securities Announcement Summary Entity name ALTERITY THERAPEUTICS LIMITED Announcement Type New announcement Date of this announcement Wednesday

Key Takeaway: Alterity Therapeutics Limited announced the cessation of 700,000 options that expired on January 31, 2023. These options, identified by ASX code ATHAI, were set to a strike price of $0.083 and have ceased due to not being exercised or converted. Following this expiration, a detailed breakdown of the company's securities indicates that the total number of ordinary fully paid shares remains at approximately 2.42 billion. The expiration and cessation of these options could affect the company's perceived market capital and future financial strategy.

Market Sentiment Analysis

CONCERNS & RISKS

  • 700,000 options expired without exercise or conversion, possibly diluting future financial flexibility.
  • Cessation of securities may impact investor confidence and market perception of the company's valuation.

Full Press Release Details

ALTERITY THERAPEUTICS LIMITED
Date of this announcement
Wednesday February 01, 2023
Details of +securities that have ceased
ASX +security code Security description Number of +securities that have ceased The +securities have ceased due to Date of cessation
ATHAI OPTION EXPIRING 31-JAN-2023 EX $0.083 700,000 Expiry of option or other convertible security without exercise or conversion 31/01/2023
to next page for full details of the announcement
ALTERITY THERAPEUTICS LIMITED
We (the entity named above) provide the following information
about our issued capital.
1.2 Registered Number Type Registration Number
ABN 37080699065
1.4 The announcement is
New announcement
ASX +Security Code and Description
ATHAI : OPTION EXPIRING 31-JAN-2023 EX $0.083
Unquoted +equity securities that have ceased
Number of securities that have ceased
Reason for cessation
Expiry of option or other convertible security without
exercise or conversion
Date of cessation Is the entity paying any consideration for the cessation?
31/1/2023 No
Any other information the entity wishes to notify to
ASX about the cessation?
the cessation of the +securities the subject of this notification, the issued capital of the entity will comprise:
ASX +security code and description Total number of +securities on issue
ATH : ORDINARY FULLY PAID 2,416,418,418
Total number of
ASX +security code and description +securities on issue
ATHAI : OPTION EXPIRING 31-JAN-2023 EX $0.083 0
ATHAAE : OPTION EXPIRING 29-NOV-2026 EX $0.0375 19,250,000
ATHAAF : OPTION EXPIRING 31-JUL-2024 EX $0.07 12,000,000
ATHAAG : OPTION EXPIRING 29-NOV-2026 EX $0.0238 13,900,000
ATHAAB : OPTION EXPIRING 17-SEP-2025 EX $0.09 35,000,000
ATHAAC : OPTION EXPIRING 23-NOV-2023 EX $0.07 674,694,939
ATHAAD : OPTION EXPIRING 06-JAN-2026 EX $0.032 91,392,720
the figures stated in the tables above are used to calculate the total market capitalisation of the entity published by ASX from time
to time. The table will not include those classes of +securities that have ceased or lapsed in their entirety in ASX records before the
announcement date described in Q1.5, even if the entity has advised ASX of a change to that class of +security in Part 2 of this form.

Frequently Asked Questions

What securities expired for Alterity Therapeutics?

The ATHAI options expiring on January 31, 2023, have ceased.

How many ATHAI options expired?

700,000 ATHAI options expired without exercise or conversion.

What is the reason for the cessation of ATHAI options?

The ATHAI options ceased due to expiry without exercise or conversion.

What will be the total securities on issue after cessation?

Post-cessation, there will be 2,416,418,418 ordinary shares on issue.

Is Alterity paying for the cessation of options?

No, Alterity is not paying any consideration for the cessation.

Last updated: Feb 1, 2023